Sherwin-Williams Posts Q1 Earnings Above Street View
Sherwin-Williams Co (NYSE:SHW) reported first-quarter FY22 sales growth of 7.4% year-on-year to $4.99 billion, beating the consensus of $4.91 billion. The…
Why Sherwin-Williams Stock Is Moving Higher
Sherwin-Williams Co (NYSE: SHW) shares are trading higher Tuesday after the company reported better-than-expected financial results.
Recap: Sherwin-Williams Q1 Earnings
Sherwin-Williams (NYSE:SHW) reported its Q1 earnings results on Tuesday, April 26, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
$1000 Invested In Sherwin-Williams 5 Years Ago Would Be Worth This Much
Sherwin-Williams (NYSE:SHW) has outperformed the market over the past 5 years by 4.81% on an annualized basis producing an average annual return of 18.04%. Currently, Sherwin-Williams has a market capitalization of $65.93 billion.
Wells Fargo Maintains Equal-Weight on Sherwin-Williams, Lowers Price Target to $275
Wells Fargo analyst Michael Sison maintains Sherwin-Williams (NYSE:SHW) with a Equal-Weight and lowers the price target from $315 to $275.
Looking Into Sherwin-williams Company’s Recent Short Interest
Sherwin-williams Company's (NYSE:SHW) short percent of float has risen 10.26% since its last report. The company recently reported that it has 3.08 million shares sold short, which is 1.29% of all regular shares that are available for trading.
Expert Ratings For Sherwin-Williams
Within the last quarter, Sherwin-Williams (NYSE:SHW) has observed the following analyst ratings:
Loop Capital Maintains Buy on Sherwin-Williams, Lowers Price Target to $300
Loop Capital analyst Garik Shmois maintains Sherwin-Williams (NYSE:SHW) with a Buy and lowers the price target from $345 to $300.
BofA: 3 Upgrades, 3 Downgrades On New Set Of Global Challenges
Corporates are facing new challenges, including the Russia-Ukraine war, COVID outbreaks in China, rising energy prices, interest rate hikes, and new supply chain disruptions, some of which could materialize into new headwinds, according to BofA Securities.
The Chemicals Analyst: Steve Byrne upgraded three stocks and downgraded three others.
10 Biggest Price Target Changes For Monday
Wells Fargo cut the price target on Gilead Sciences, Inc. (NASDAQ: GILD) from $70 to $63. Gilead Sciences shares rose 0.4% to $59.91 in pre-market trading.